It’s the one injectable buprenorphine that delivers both of those weekly and regular dosing alternatives. BRIXADI is indicated for that treatment of average to severe opioid use condition (OUD) in patients who have initiated treatment with an individual dose of the transmucosal buprenorphine products or who're currently getting handled with bupre